Bosch expands downstream portfolio for syringes
Flexible processing of pre-sterilized syringes.
Bosch Packaging Technology is further expanding its line competence in the filling and processing of pre-sterilized syringes. “After successfully establishing our fill-finish portfolio, we also strengthen our line competence in downstream processes,” says Klaus Ullherr, product manager at Bosch Packaging Technology. “Two steps are required: the rod has to be inserted and the pre-filled syringes have to be inspected. The USD de-nester and the RIL rod insertion and labelling machine are ideal additions to our filling and closing machines, such as the recently launched FXS Combi.” First machine combinations are already in operation in Europe and Asia.
Gentle removal and transportation
The syringes filled with liquid pharmaceuticals are either manually or automatically placed on the infeed belt of the de-nester in tubs. Using a gripper, the USD removes the syringes in rows and gently transfers them to a horizontal single-lane transport belt. The products remain in a safe and controlled position at all times. Depending on the model, the USD de-nester achieves an output of up to 400 syringes per minute. In combination with the respective inspection machines for particle and cosmetic inspection as well as leak detection, a ZPS buffer system and a RIL rod insertion and labelling machine, lines for middle and high performance can be implemented.
Safety for products, operators and patients
The high-performance machines of the RIL series accomplish exact and gentle rod insertion, and provide for reliable labelling of the syringes. First, the transport belt transfers the syringes to a segment wheel, which ensures that screwing in of the rod is done at optimum conditions in standstill mode. A separate sorting device conveys the rods to a star wheel, which positions the rods and inserts them accurately into the rubber stoppers. The torque control makes sure that the stoppers do not move. In the next step, the segment wheel transfers the syringes to the labelling station, where the labels are applied and checked with a control sensor. A number of additional options are available to read out label data or inspect the quality, readability and coding of the labels.
To ensure optimum product and operator safety as well as high product quality, the RIL models are equipped with a tip closure control, which checks the presence of the protecting cap on the injection needle. All defect syringes are conveyed to a customer-specific reject station via a star wheel. After rod insertion, labelling and inspection, the processed syringes can be additionally equipped with a backstopper on the RIL. Designed for patient safety and ease of use, the stopper prevents the plunger head from being pulled out of the syringe and also broadens the finger flange.
First machine combinations in operation
“The downstream equipment is an important part of our line competence for syringes,” says Klaus Ullherr. “The new models meet the requirements in the European, as well as in the growing Asian market. Our specialists have already delivered, installed and put into operation several machines together with our customers.” Further steps for a consequent portfolio expansion are in the planning stage, such as the integration of so-called safety devices for syringes.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance